Overview

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Status:
Not yet recruiting
Trial end date:
2025-03-30
Target enrollment:
Participant gender:
Summary
Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.
Phase:
Early Phase 1
Details
Lead Sponsor:
Hackensack Meridian Health
Treatments:
Ibuprofen
Misoprostol
Ondansetron